Is BYAH or CLX more undervalued in 2026?

CirclFi compares Park Ha Biological Technology C (BYAH) and Clorox Company (The) (CLX) using 13 institutional-grade valuation models. BYAH has a Quality of Company score of 2.3/10 while CLX scores 8.7/10.

Which is a better buy — BYAH or CLX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BYAH and CLX valuations compare?

BYAH at $1.20 and CLX at $96.20 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BYAH vs CLX Valuation Comparison 2026 — Intrinsic Value Analysis

BYAH

Household & Personal Products

Park Ha Biological Technology C

Quality

2.3

out of 10

Value Trap

—

Price

$1.20

Last close

Models

11/13

Active

CLX

Household & Personal Products

Clorox Company (The)

Quality

8.7

out of 10

Value Trap

—

Price

$96.20

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	BYAH Fair Value	BYAH Upside	CLX Fair Value	CLX Upside
Bayesian DCF	Intrinsic	$0.24	-80.2%	$69.17	-28.1%
Earnings Power Value	Intrinsic	$0.30	-73.2%	$45.79	-52.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BYAH vs CLX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BYAH vs CLX — Which Stock Is More Undervalued?

CLX scores higher with a 8.7/10 quality rating vs BYAH's 2.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Park Ha Biological Technology C (BYAH) and Clorox Company (The) (CLX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BYAH currently trades at $1.20 with a QOC of 2.3/10, while CLX trades at $96.20 with a QOC of 8.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).